Flexomics is a small, recently established biotech structured around building solutions for personalized genomics at unprecedented scale. Initially in the university setting and now as an entrepreneur, principals of the firm are developing a functional and genomic analysis technology: the next generation of screening platform designed seamlessly to integrate state-of-the art cell imaging and the most recent advances in single-cell genomics
